ANI Pharmaceuticals CFO Stephen Carey Exercises Options and Sells Shares Under 10b5-1 Plan

ANI Pharmaceuticals Inc. (ANIP) CFO Stephen P. Carey executed a stock option exercise and sale transaction on July 2, 2026, pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2026. Carey exercised options to purchase 3,313 shares at $49.51 per share, then immediately sold the same number of shares at $86.00 per share. The options were part of a vesting schedule with quarterly vesting from March 2018 through March 2021 and expire on March 30, 2027. Following these transactions, Carey's direct holdings in ANI Pharmaceuticals common stock decreased from 180,856 shares to 177,543 shares. The transactions represent a routine executive stock transaction under a pre-established trading plan, which is designed to avoid allegations of insider trading.